These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Uveitis in adult patients with rheumatic inflammatory autoimmune diseases at a tertiary-care hospital in Mexico City. Jiménez-Balderas FJ; Fernandez-Arrieta G; Camargo-Coronel A; Ake-Uc MÁ; Vazquez-Zaragoza MA; Zonana-Nacach A; Sánchez-González LR; Rios R; Martinez-Castro F J Rheumatol; 2011 Feb; 38(2):325-30. PubMed ID: 21123327 [TBL] [Abstract][Full Text] [Related]
27. Managing IBD outside the gut: ocular manifestations. Calvo P; Pablo L Dig Dis; 2013; 31(2):229-32. PubMed ID: 24030231 [TBL] [Abstract][Full Text] [Related]
28. Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020. Pournazari M; Hashemi T; Zarpoosh M; Amirian P Immun Inflamm Dis; 2023 May; 11(5):e863. PubMed ID: 37249299 [TBL] [Abstract][Full Text] [Related]
29. Eye diseases in general out-patient clinic in Ibadan. Scott SC; Ajaiyeoba AI Niger J Med; 2003; 12(2):76-80. PubMed ID: 12956012 [TBL] [Abstract][Full Text] [Related]
30. Vitiligo and ocular findings: a study on possible associations. Bulbul Baskan E; Baykara M; Ercan I; Tunali S; Yucel A J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):829-33. PubMed ID: 16898906 [TBL] [Abstract][Full Text] [Related]
31. Ocular manifestations associated with brucellosis: a 26-year experience in Peru. Rolando I; Olarte L; Vilchez G; Lluncor M; Otero L; Paris M; Carrillo C; Gotuzzo E Clin Infect Dis; 2008 May; 46(9):1338-45. PubMed ID: 18419433 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825 [TBL] [Abstract][Full Text] [Related]
33. Sex- and gender-based differences in healthy and diseased eyes. Wagner H; Fink BA; Zadnik K Optometry; 2008 Nov; 79(11):636-52. PubMed ID: 19811761 [TBL] [Abstract][Full Text] [Related]
34. [Extracorporeal treatments for some autoimmune eye diseases]. Razumova IIu; Safonova TN; Komov VV; Fedorov AA Vestn Oftalmol; 2010; 126(3):21-5. PubMed ID: 20608194 [TBL] [Abstract][Full Text] [Related]
35. Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers. Dammacco R; Procaccio P; Racanelli V; Vacca A; Dammacco F Ocul Immunol Inflamm; 2018; 26(8):1154-1165. PubMed ID: 30096011 [TBL] [Abstract][Full Text] [Related]
36. Posterior segment involvement in Korean patients with HLA-B27-associated uveitis. Kim SJ; Chung H; Yu HG Ocul Immunol Inflamm; 2009; 17(1):26-32. PubMed ID: 19294570 [TBL] [Abstract][Full Text] [Related]
37. Incidence and prevalence of glaucoma in severe ocular surface disease. Tsai JH; Derby E; Holland EJ; Khatana AK Cornea; 2006 Jun; 25(5):530-2. PubMed ID: 16783140 [TBL] [Abstract][Full Text] [Related]
38. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Fukaya S; Yasuda S; Hashimoto T; Oku K; Kataoka H; Horita T; Atsumi T; Koike T Rheumatology (Oxford); 2008 Nov; 47(11):1686-91. PubMed ID: 18782855 [TBL] [Abstract][Full Text] [Related]
39. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Grasland A; Pouchot J; Hachulla E; Blétry O; Papo T; Vinceneux P; Rheumatology (Oxford); 2004 Aug; 43(8):1007-15. PubMed ID: 15150435 [TBL] [Abstract][Full Text] [Related]